CALGARY, AB — hyperCORE International is pleased to welcome CaRe Clinic, based in Alberta, Canada to its collaborative super network of clinical trial sites, as the clinical research organization continues to expand its global reach and capabilities through alliance partnerships.
CaRe Clinic is a growing high quality, multi-specialty research organization working to redefine the landscape of medical research in Canada. The organization has two state-of-the-art, dedicated research centers serving Calgary as well as Red Deer and the central regions of Alberta. The clinical team has participated in hundreds of clinical trials in areas such as women’s health, dermatology, general medicine, vaccines, infectious diseases and migraine treatments. Powered by a broad combination of investigators’ patient databases and their strong partnerships with affiliated clinics, the clinics have access to a reservoir of over 1.8 million potential patients. CaRe Clinic’s community-centric recruitment strategy has also created unparalleled potential for participant recruitment across almost all medical indications.
Troy Hamilton, Director of Operations at CaRe Clinic shared, “At CaRe Clinic, we are continuously looking for opportunities to improve how we deliver clinical trials. Joining hyperCORE International was a chance to do just this. This partnership opens doors for unprecedented collaboration and the sharing of best practices across borders, which is crucial for the advancement of clinical research. We aim to highlight Canada’s robust clinical research ecosystem on the global stage and contribute to pioneering breakthroughs that will benefit patients worldwide.”
Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, also shared, “hyperCORE welcomes CaRe Clinic to their super network with open arms. This immediately increases hyperCORE’s footprint at multiple locations in Canada with a multi-therapeutic offering and adds a solid partner to the team. We are excited to start working closely with the CaRe Clinic team!”
hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. It is an industry leader, providing Phase I-IV clinical trial services with more than 120 active research sites on two continents and five countries. Each of its alliance partners have decades of clinical research experience and have collectively completed more than 7,000 studies helping to evaluate thousands of new drugs and treatments in more than 150,000 randomized patients. Each partner operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.
hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation.
